Streetbeat News

Analyst Ratings

CBOE

Rosenblatt analyst Andrew Bond has maintained a Buy rating on Cboe Global Markets (CBOE) and increased the price target from $192 to $200.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 12:43 pm

ZS

Rosenblatt analyst Catharine Trebnick has reiterated a Buy rating on Zscaler (NASDAQ:ZS) and maintained a price target of $245. This reaffirms Rosenblatt's positive outlook on Zscaler's stock.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 12:40 pm

HIG

Raymond James analyst C. Gregory Peters maintains an Outperform rating on Hartford Financial Services Group (HIG) and raises the price target from $90 to $100.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 12:37 pm

PHM

Raymond James analyst Buck Horne has maintained an Outperform rating on PulteGroup (NYSE:PHM) and raised the price target from $100 to $120.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 12:36 pm

NOV

Raymond James analyst James Rollyson maintains an Outperform rating on NOV Inc. (NYSE:NOV) and lowers the price target from $28 to $25.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 12:34 pm

APD

CAT

QQQ

SPY

U.S. stock futures dipped in Monday's premarket as Federal Reserve Chair Jerome Powell maintained a hawkish stance in a '60 Minutes' interview, emphasizing caution towards rate cuts. This stance, combined with an earnings-heavy week, has introduced caution among traders. Last week, mixed earnings reports from major companies like Alphabet, Apple, Amazon, and Meta influenced market movements, with the Dow Industrials and S&P 500 hitting fresh records. SPDR S&P 500 ETF Trust (SPY) and Invesco QQQ ETF (QQQ) saw premarket movements. Companies like Caterpillar Inc. (CAT) and Air Products and Chemicals, Inc. (APD) showed significant premarket price changes following their earnings reports.

Portfolio Pulse from Shanthi Rexaline

February 05, 2024 | 12:26 pm

GFF

Raymond James analyst Sam Darkatsh maintains a Strong Buy rating on Griffon (NYSE:GFF) and raises the price target from $60 to $75.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 12:26 pm

ABBV

Raymond James analyst Gary Nachman maintains an Outperform rating on AbbVie (NYSE:ABBV) and raises the price target from $181 to $189.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 12:24 pm

SDHC

Wolfe Research analyst Truman Patterson has initiated coverage on Smith Douglas Homes (NYSE:SDHC) with a Peer Perform rating, indicating a neutral outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 12:18 pm

UTHR

Leerink Partners has initiated coverage on United Therapeutics (NASDAQ:UTHR) with an Outperform rating and set a price target of $330.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 12:15 pm